Cadenza Bio
2 known investors
Cadenza Bio develops small-molecule drugs for oral administration to treat demyelinating and inflammatory diseases. The company focuses on halting disease progression and promoting tissue repair in patients with debilitating conditions.
BiotechFemTechMedical Devices
Founders & leadership
CC
Carol Curtis, PhDChief Executive Officer, Founder
EH
Elaine Hamm, PhDChief Operating Officer, Founder
JK
John Katzenellenbogen, PhDScientific Founder
ST
Seema Tiwari-Woodruff, PhDScientific Founder
Investors · 2
In the news
- Why We Invested: Cadenza Bio - Cortado Venturescortado.ventures · 2024
- Plains Ventures Leads Investment in Biotech Company Cadenza Bio, Inc. - Plains Venturesplainsvc.com · 2024
- Cadenza Bio, Inc. Secures $2.44M in Oversubscribed Series Seed Financing — Cadenza Biocadenza.bio · 2023
- Cadenza Bio - BIO Investment & Growth Summit 2026bigs.bio.org